With the introduction of the concurrent myocardial blood flow (MBF) quantification in ml/g/min with positron emission tomography/computed tomography (PET/CT) assessment of myocardial perfusion in clinical routine, the scope of conventional scintigraphic myocardial perfusion imaging now expands from the identification of the most advanced and culprit CAD lesion, as signified by the stress-induced regional myocardial perfusion defect, also to less severe but flow-limiting stenosis in multivessel CAD. Thus, by adding regional MBFs determined at rest and during vasomotor stress with the resulting myocardial flow reserve (MFR=MBF during stress/MBF at rest) to conventional myocardial perfusion PET/CT, a comprehensive identification and characterization of flowlimiting effects of multivessel CAD has become feasible. The non-specific nature of the hyperemic MBF increase and MFR, however, necessitates an evaluation and interpretation of regional hyperemic MBFs in the appropriate context with coronary morphology, microvascular function, and wall motion analysis in patients with CAD. Such a diagnostic approach may foster a more individualized and image-guided decision making process towards coronary revascularization procedures in patients with complex multivessel CAD that, however, remains to be tested in clinical outcome studies.
that a normalization thereof by standard preventive medical intervention may indeed result an improved cardiovascular outcome as compared to those with without normalization of vascular function (29, 30) . Since different regulatory mechanisms of the coronary and peripheral microcirculations in the diseased and normal vascular states apply, extrapolations between findings in the two vascular beds may be misleading (31, 32) . Of note, coronary circulatory dysfunction has widely been realized as a useful integrating index of the overall stress burden by various cardiovascular risk factors on the arterial wall, taking into account the cumulative risk of cardiovascular risk factors and as yet unknown variables and genetic predispositions (15, 31) . If this holds true, then a marked improvement or normalization of coronary circulatory function in cardiovascular risk individuals should also counterbalance the manifestation and/or progression of a CAD process and improve cardiovascular outcome. Such consideration is also supported by a recent investigation with PET/CT flow measurements in type 2 diabetes mellitus patients (24) .
Currently more of clinical interest, however, is the application of hyperemic MBF and MFR in patients with advanced multivessel CAD (6) , as it expands the scope of conventional scintigraphic myocardial perfusion imaging from the identification of the most advanced and culprit CAD lesion, as signified by the stress-induced regional myocardial perfusion defect, also to less severe but flow-limiting stenosis in multivessel CAD (3, 6) . This review strives to provide a framework of various diagnostic scenarios of PET/CTdetermined myocardial perfusion and flow quantification in the detection and characterization of clinically manifest CAD (Table 1) .
Stenosis, ischemia and hyperemic MBFs
Pioneer investigations by Gould et al. (33) (34) (35) (36) , that were expanded and confirmed by subsequent clinical studies (37) (38) (39) , demonstrated that hyperemic MBFs during pharmacologic vasodilation commonly decreased when a lesion exceeded 50% of luminal diameter (37) (38) (39) (40) . Despite this well described relationship between CAD lesions and MFR, individual hyperemic flows may underlie a substantial variety owing to different degree of adaptive vasodilation of the coronary microcirculation to compensate for downstream, flowlimiting effects of epicardial CAD lesions and/or the presence of collateral flow (16, 41, 42) . In this respect, relatively maintained regional hyperemic MBF or MFR may through physical exercise or preventive medical care like in the "clinical outcomes utilizing revascularization and aggressive drug evaluation" (COURAGE) trial or the development of collateral flow indeed counterbalance the manifestation of stress-induced myocardial ischemia (43) . This again provides some rationale for the observed relatively low prevalence of only about 30% of myocardial ischemia in the presence of epicardial narrowing ≥50% (44, 45) . As regards reductions of hyperemic MBFs, they may be related to adverse effects of cardiovascular risk factors induced increases in oxidative stress burden and inflammation within the coronary arteriolar wall in the absence of any CAD (31, 46, 47) . Consequently, the relatively low specificity of reductions in hyperemic MBFs alone cannot certainly signify obstructive and flow-limiting CAD in multivessel CAD. It is important to consider that with increasing severity of CAD induced epicardial narrowing, the vascular resistances shift from the microcirculation to the site of epicardial stenosis as the adaptive vasodilation becomes exhausted ( Fig. 1) (34-36, 48 ). In patients with multivessel 13 N-ammonia perfusion images, a moderate decrease in radiotracer uptake of the midto-distal anterior, anteroseptal, and apical regions of the left ventricle can be observed, that becomes reversible on the rest images to signify ischemia in the LAD distribution.
13 N-ammonia uptake, however, is widely preserved in the lateral and inferior regions. (b) Quantification of MBFs demonstrates globally reduced MFR with a regional MFR of 1.20 in the LAD-, 1.41 in the LCx-, and 1.35 in the RCA-distribution, respectively. (c) Invasive coronary angiography demonstrates significant three vessel disease with proximal occlusion of the LAD, 80% stenosis in the proximal segments of the LCX (left panel), and sequential 50% to 60% lesions in the RCA (right panel). When defining flow-limiting CAD with epicardial stenosis >70% and MFR <1.7 (criteria: +/+), then apart from the proximal LAD occlusion, the LCx lesion of less and intermediate severity (≈80%) is also appreciated as hemodynamic significant despite normal radiotracer uptake. As regards the RCA, only one criteria applies. While regional MFR is markedly reduced with 1.35, the serial lesions of 50% do not reach the threshold of > 70% diameter stenosis (criteria: -/+). Thus, the marked decrease in MFR in the RCA distribution may predominantly reflect microvascular dysfunction and not hemodynamically obstructive CAD. (Reproduced with kind permission from references (3, 6) 
The diagnostic challenge: diffuse ischemia
The evaluation of myocardial perfusion is based on the stress as well as the LVEF reserve afford a differentiation between significant left main and/or three vessel CAD induced diffuse ischemia, its exclusion, and the presence of predominantly microvascular dysfunction that, however, should be further confirmed in more large-scale clinical investigations.
In ischemic cardiomyopathy patients with pre-existing low left ventricular function, the latter outlined scenario may not be applicable any more. Ischemic preconditioning of the heart portends a certain cardioprotection that strives to counterba- In individuals with normal stress-rest myocardial perfusion images, the quantification of hyperemic MBF and MFR may unmask microvascular dysfunction as functional precursor of CAD that may reinforce lifestyle-changes and/or preventive medical care. A stress-induced regional perfusion defect, however, signifies the"culprit"or most advanced CAD lesion. In this respect, adding hyperemic MBF and MFR may signify flow-limiting effects of lesions >70% diameter but less severe than observed for the culprit lesions and with normal radiotracer-uptake. (Reproduced with kind permission from reference (6)). Since on gated PET left-ventricular wall motion is normal associated with a leftventricular ejection fraction (LVEF) of 77% at rest and also at peak stress, respectively, diffuse myocardial ischemia potentially related to the left main lesion can be excluded. In the absence of a global hypokinesis during"peak"stress without a drop in LVEF during stress from rest, the pronounced decreases in hyperemic MBFs and MFR in all three major coronary territories do not represent diffuse myocardial ischemia but rather reflect cardiovascular risk factors caused microvascular dysfunction. (Reproduced with kind permission from reference (1) In patients without cardiomyopathy or normal left-ventricular function, a stress-induced regional perfusion defect identifies the "culprit" or most advanced CAD lesion. In addition, reduced hyperemic MBF and MFR may signify flow-limiting effects of lesions >70 % diameter stenosis in patients with ischemic cardiomyopathy. Normal perfusion imaging, however, may not rule out diffuse ischemia due to significant left main and/or three vessel disease. While normal hyperemic MBFs and MFRs may widely excludes high risk CAD, reductions in hyperemic MBFs may be seen as non-specific. Abnormal hyperemic MBFs may suggest diffuse microvascular function or diffuse ischemia in these cardiomyopathy patients. In this setting, the additional wall motion analysis of the left ventricle at peak stress is not likely to be of much help as left-ventricular function is severely reduced in most patients and a further significant drop in left-ventricular ejection fraction is not to be expected due to ischemic conditioning or cardioprotective effects. Thus, given normal perfusion but abnormal hyperemic MBFs in cardiomyopathy patients, invasive or non-invasive coronary angiography may be considered to triage these high risk patients to coronary revascularization procedures or medical treatment alone. (Reproduced with kind permission from reference (6)).
